• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐形脂质体对冬凌草甲素的药代动力学、组织分布及抗肿瘤活性的影响

The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin.

作者信息

Wang Chuanjin, Wei Yunyang, Yu Li, Zhang Liang

机构信息

Department of Pharmaceutical Engineering, Institute of Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, PR China.

出版信息

PDA J Pharm Sci Technol. 2009 Sep-Oct;63(5):409-16.

PMID:20158047
Abstract

High-purity oridonin was isolated and identified from Rabdosia rubescens hemsl by preparative high-performance liquid chromatography (HPLC). Stealth liposomes of oridonin were prepared by thin-film ultrasonic dispersion using polyethylene glycol-distearoylphosphatidyleth-anolamine(PEG2000-DSPE) as the surface-coating material. A reversed-phase HPLC method was developed and validated to determine the concentrations of oridonin in the serum and tissues of mice. The tissue distribution and pharmacokinetics of oridonin stealth liposomes and oridonin solution in mice were investigated. The results showed that the distribution and pharmacokinetics of oridonin stealth liposomes in mice were changed as compared to the distribution and pharmacokinetics of oridonin solution. The levels of stealth liposomal oridonin in the heart tissues were reduced, while the levels of stealth liposomal oridonin in the blood were increased. The stealth liposomes were very effective at inhibiting the rate of solid tumor growth. The PEG2000-DSPE of liposomes prolonged the circulation time of oridonin in mouse blood, reduced accumulation in the reticuloendothelial system and increased the anti-tumor activity of oridonin.

摘要

采用制备型高效液相色谱法(HPLC)从溪黄草中分离并鉴定出高纯度冬凌草甲素。以聚乙二醇-二硬脂酰磷脂酰乙醇胺(PEG2000-DSPE)作为表面包覆材料,通过薄膜超声分散法制备冬凌草甲素隐形脂质体。建立并验证了一种反相HPLC方法,用于测定小鼠血清和组织中冬凌草甲素的浓度。研究了冬凌草甲素隐形脂质体和冬凌草甲素溶液在小鼠体内的组织分布和药代动力学。结果表明,与冬凌草甲素溶液相比,冬凌草甲素隐形脂质体在小鼠体内的分布和药代动力学发生了变化。心脏组织中隐形脂质体冬凌草甲素的含量降低,而血液中隐形脂质体冬凌草甲素的含量增加。隐形脂质体对抑制实体瘤生长速率非常有效。脂质体的PEG2000-DSPE延长了冬凌草甲素在小鼠血液中的循环时间,减少了在网状内皮系统中的蓄积,并增强了冬凌草甲素的抗肿瘤活性。

相似文献

1
The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin.隐形脂质体对冬凌草甲素的药代动力学、组织分布及抗肿瘤活性的影响
PDA J Pharm Sci Technol. 2009 Sep-Oct;63(5):409-16.
2
[The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].冬凌草甲素-固体脂质纳米粒在小鼠体内的组织分布及在兔体内的药代动力学
Yao Xue Xue Bao. 2005 Jun;40(6):573-6.
3
Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.载紫杉醇隐形脂质体:研发、表征、药代动力学及生物分布
Artif Cells Nanomed Biotechnol. 2016;44(1):350-5. doi: 10.3109/21691401.2014.951722. Epub 2014 Aug 27.
4
Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.冬凌草甲素纳米混悬液的药代动力学及组织分布研究
Int J Pharm. 2008 May 1;355(1-2):321-7. doi: 10.1016/j.ijpharm.2007.12.016. Epub 2007 Dec 23.
5
Antiangiogenic effects of oridonin.冬凌草甲素的抗血管生成作用。
BMC Complement Altern Med. 2017 Apr 4;17(1):192. doi: 10.1186/s12906-017-1706-3.
6
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.冬凌草甲素与三氧化二砷联合对肝癌细胞的协同抗肿瘤作用。
Int J Oncol. 2012 Jan;40(1):139-47. doi: 10.3892/ijo.2011.1210. Epub 2011 Sep 22.
7
Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.载有冬凌草甲素的聚(ε-己内酯)-聚(环氧乙烷)-聚(ε-己内酯)共聚物纳米粒:制备、表征及其对移植性肝癌小鼠的抗肿瘤活性
J Drug Target. 2008 Jul;16(6):479-85. doi: 10.1080/10611860802200938.
8
Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.冬凌草甲素(一种从冬凌草中分离出的二萜类化合物)对caspase-9的抑制作用增强了人喉癌细胞的凋亡。
Int J Oncol. 2015 Dec;47(6):2045-56. doi: 10.3892/ijo.2015.3186. Epub 2015 Sep 28.
9
[Preparation of freeze-dried long-circulation oridonin liposomes and their pharmacokinetics in rats].[冻干粉针剂的长循环冬凌草甲素脂质体的制备及其在大鼠体内的药代动力学]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Nov;42(6):638-43. doi: 10.3785/j.issn.1008-9292.2013.06.008.
10
Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.蛋白质组学鉴定冬凌草甲素在 HepG2 细胞中抗癌活性相关的蛋白。
Phytomedicine. 2011 Jan 15;18(2-3):163-9. doi: 10.1016/j.phymed.2010.06.011. Epub 2010 Aug 17.

引用本文的文献

1
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin.增强癌症治疗效果:用于冬凌草甲素的先进纳米载体递送系统
Front Pharmacol. 2024 Dec 3;15:1476739. doi: 10.3389/fphar.2024.1476739. eCollection 2024.
2
Research and Development Progression of Oridonin for Hematological Malignancies Therapy.冬凌草甲素用于血液系统恶性肿瘤治疗的研发进展
Curr Med Chem. 2025;32(23):4713-4724. doi: 10.2174/0109298673273034231215190811.
3
Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy.
基于纳米技术的药物递送以提高NRF2调节剂在癌症治疗中的治疗效果。
Antioxidants (Basel). 2021 Apr 27;10(5):685. doi: 10.3390/antiox10050685.
4
Solubility and Bioavailability Enhancement of Oridonin: A Review.冬凌草甲素增溶和生物利用度提高的研究进展:综述
Molecules. 2020 Jan 14;25(2):332. doi: 10.3390/molecules25020332.